Discover 1,161 paid clinical trials in Waterbury, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,161
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: New Haven CT, New York NY, Boston MA, Baltimore MD,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06040541
Phase 1, Recruiting
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
for
Breast Cancer
Location: New Haven CT, Stony Brook NY, New York NY, Albany NY,
Sponsor: Greenwich LifeSciences, Inc.
Sex: All
Age: 18 - 70+
Code: NCT05232916
Phase 3, Recruiting
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
for
Ovarian Cancer, Fallopian Tube Cancer,
Location: New Haven CT, Mineola NY, Hackensack NJ, New York NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT06824467
Phase 3, Recruiting
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
for
Stage III Ovarian Cancer, Stage IV Ovarian Cancer,
Location: New Haven CT, Hartford CT, Teaneck NJ, New York NY,
Sponsor: GOG Foundation
Sex: Female
Age: 18+
Code: NCT05659381
Phase 3, Recruiting
A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: New Haven CT, Providence RI, Toronto, Detroit MI,
Sponsor: Eikon Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06253130
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
for
Deep Venous Thrombosis
Location: New Haven CT, Valhalla NY, New York NY, Philadelphia PA,
Sponsor: Yale University
Sex: All
Age: 0 - 17
Code: NCT04924322
Phase 2, Phase 3, Recruiting
Unified Network for Integrated Fluid Collection at Yale
for
Molecular Residual Disease, Cancer
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT07689864
Recruiting
A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors
for
Advanced or Metastatic Solid Tumors
Location: New Haven CT, Philadelphia PA, Baltimore MD, Fairfax VA,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT07205718
Phase 1, Phase 2, Recruiting
A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)
for
Sarcoma,Soft Tissue
Location: New Haven CT, Philadelphia PA, Toronto, Durham NC,
Sponsor: Intensity Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06263231
Phase 3, Recruiting
Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal Cancer
for
Advanced Microsatellite Stable Colorectal Cancer
Location: North Haven CT, Boston MA, Charlottesville VA,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT07527858
Phase 2, Recruiting
A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination With Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants With First-Line Metastatic Pancreatic Ductal Adenocarcinoma
for
Metastatic Pancreatic Ductal Adenocarcinoma, PDAC
Location: New Haven CT, Philadelphia PA, Fairfax VA, Cleveland OH,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07490301
Phase 2, Phase 3, Recruiting
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
Location: New Haven CT, Trumbull CT, Fairfax VA, Nashville TN,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07519655
Phase 1, Recruiting
Lung Ultrasound for Guiding Antibiotic Use in Pediatric Pneumonia
for
Pneumonia Childhood, Pneumonia, Lung Ultrasound,
Location: New Haven CT
Sponsor: Meyer Children's Hospital IRCCS
Sex: All
Age: 3 - 10
Code: NCT06921993
Recruiting
Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels